China

Our earliest work was in China, where in 1979 we started helping the government make contraception widely accessible. Our partnerships here are still growing, and we’re working across sectors to close a wide range of health gaps--here in China and beyond.

Contact Us

1 Xindong Road
Tayuan Diplomatic Residence Compound
Room 51, Suite 1, Building 3
Chaoyang District
Beijing 100600, PR China

Phone: 86.10.8528.8211
Fax: 86.10.8528.8210

Our Work
Related articles

Read our latest

14 Article s
  1. PATH diagnostics training China COVID-19 TB
    March 24, 2020

    Leveraging the COVID-19 response to fight tuberculosis in China

    Tackling tuberculosis in China through structural changes in service delivery, financial policy reform, new diagnostic tools, and delivery innovations.

  2. Chinese JE vaccine in use in India, photo PATH/Julie Jacobson.
    August 20, 2019

    How a little-known vaccine in China became a global lifesaving tool

    A Chinese vaccine manufacturer and PATH partnered to scale a lifesaving vaccine, protecting millions of children across Asia from deadly Japanese encephalitis.

  3. Myanmar Japanese encephalitis vaccination campaign 2017
    April 24, 2019

    No longer neglected—the story (behind the story) of the Japanese encephalitis vaccine

    Dr. Nihal Abeysinghe and Dr. Kathleen Neuzil are pioneers of a nearly two-decade effort to prevent and control Japanese encephalitis (JE).

  4. Health center staff with Dr. Mukergee and children standing in front of Japanese Encephalitis poster, West Bengal, India, July 2006
    October 30, 2018

    Japanese encephalitis—no longer neglected: A model for other new vaccines

    No longer neglected? Japanese encephalitis is a model for new vaccines to prevent other tropical diseases.

  5. A woman gives a girl an injection as others wait behind her.
    September 20, 2018

    How a once little-used vaccine now protects millions from Japanese encephalitis

    An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 20-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached more than 300 million children—a turning point in the battle to protect people from this dreaded disease.

  6. A close-up of water being poured into an MSR SE200 Community Chlorine Maker (electrochlorinator) held in one hand.
    June 26, 2018

    We're powered by more than 40 years of partnerships

    At PATH, we connect local innovators and decision-makers with our global network of partners to develop responsive, human-centered solutions to health challenges.